X
NEO icon

Xponance’s NeoGenomics NEO Stock Holding History

Xponance’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
12,623
+859
+7% +$8.29K ﹤0.01% 1627
2026
Q1 		$87.3K Buy
11,764
+1,647
+16% +$17.3K ﹤0.01% 1586
2025
Q4 		$119K Buy
10,117
+53
+0.5% +$572 ﹤0.01% 1454
2025
Q3 		$77.7K Buy
10,064
+57
+0.6% +$399 ﹤0.01% 1459
2025
Q2 		$73.2K Buy
+10,007
New +$80.8K ﹤0.01% 1435
2021
Q4 		– Sell
-6,564
Closed -$317K – 1186
2021
Q3 		$317K Sell
6,564
-878
-12% -$40.6K 0.01% 1032
2021
Q2 		$336K Buy
+7,442
New +$330K 0.01% 1044

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Xponance's NEO Position: Q2 2026 in Review

Xponance increased its NeoGenomics (NEO) stake by 7.3% in Q2 2026, buying an estimated $8.29K and bringing the position to 12,623 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1627.

Xponance first reported a position in NEO in Q2 2021 and has held it in 7 quarters since. The position peaked at $336K in Q2 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Xponance held 12,623 shares of NeoGenomics worth $184K as of Q2 2026.
  • Xponance bought 859 NeoGenomics shares in Q2 2026, an estimated $8.29K.
  • NeoGenomics made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1627 holding.
  • Xponance first reported a position in NeoGenomics in Q2 2021 and has held it in 7 quarters since.
  • Xponance's NeoGenomics position peaked at $336K in Q2 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.